170 related articles for article (PubMed ID: 9851779)
1. Decrease of telomere length in thyroid adenomas without telomerase activity.
De Deken X; Vilain C; Van Sande J; Dumont JE; Miot F
J Clin Endocrinol Metab; 1998 Dec; 83(12):4368-72. PubMed ID: 9851779
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and telomere length in benign and malignant human thyroid tissues.
Kammori M; Takubo K; Nakamura K; Furugouri E; Endo H; Kanauchi H; Mimura Y; Kaminishi M
Cancer Lett; 2000 Oct; 159(2):175-81. PubMed ID: 10996729
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D
J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147
[TBL] [Abstract][Full Text] [Related]
8. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
Maruyama Y; Hanai H; Kaneko E
Nihon Rinsho; 1998 May; 56(5):1186-9. PubMed ID: 9613119
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in benign and malignant human thyroid tissues.
Cheng AJ; Lin JD; Chang T; Wang TC
Br J Cancer; 1998 Jun; 77(12):2177-80. PubMed ID: 9649130
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
11. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells.
Jones CJ; Soley A; Skinner JW; Gupta J; Haughton MF; Wyllie FS; Schlumberger M; Bacchetti S; Wynford-Thomas D
Exp Cell Res; 1998 May; 240(2):333-9. PubMed ID: 9597006
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
14. Changes in telomerase activity and telomere length during human T lymphocyte senescence.
Pan C; Xue BH; Ellis TM; Peace DJ; Díaz MO
Exp Cell Res; 1997 Mar; 231(2):346-53. PubMed ID: 9087176
[TBL] [Abstract][Full Text] [Related]
15. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
16. Telomere length in normal and neoplastic canine tissues.
Cadile CD; Kitchell BE; Newman RG; Biller BJ; Hetler ER
Am J Vet Res; 2007 Dec; 68(12):1386-91. PubMed ID: 18052745
[TBL] [Abstract][Full Text] [Related]
17. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
19. Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
Wang Y; Meeker AK; Kowalski J; Tsai HL; Somervell H; Heaphy C; Sangenario LE; Prasad N; Westra WH; Zeiger MA; Umbricht CB
Am J Pathol; 2011 Sep; 179(3):1415-24. PubMed ID: 21763260
[TBL] [Abstract][Full Text] [Related]
20. Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Kammori M; Nakamura K; Kanauchi H; Obara T; Kawahara M; Mimura Y; Kaminishi M; Takubo K
World J Surg; 2002 Sep; 26(9):1083-7. PubMed ID: 12209236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
